Dr Thomas Lönngren

Biography

Thomas Lönngren is the former Executive Director of the European Medicines Agency, EMA and he previously served with the Swedish Board of Health and Welfare as Director of Operations and later Deputy Director General at the Swedish Medical Products Agency (MPA). Thomas established the EMA from a relatively small-unknown agency in 2001 to a world-renowned regulatory agency in 2010 and was responsible for all of its operations. Stepping down after 10 years’ service he is currently Director at his own independent consultancy, Pharma Executive Consulting, offering strategic advice to the healthcare and pharmaceutical sector in the area of Drug Development focusing on Regulatory and Market access aspects. During 2011, Thomas was a member of the board of CIBIO in Brisbane, Australia. Through his consultancy his main work is as Strategic Advisor at NDA Group AB and its clients. His focus over the last two years has been advising US based biotech companies located in US, Boston, Cambridge, New York and San Francisco. Thomas is currently serving on several Advisory Boards and frequently speaks at conferences around the world US, Europe, Japan and Australia. He is currently a board member of Global Kinetics Corporation in Melbourne and Analytica Ltd in Brisbane Australia and is also an advisor to GLG New York, CIRS UK, Scientificmed Sweden, Molecular Warehouse UK and Pictet Asset Management, Switzerland. He is Honorary Member of the Royal Pharmaceutical Society of Great Britain, Honorary Fellow of the Royal College of Physicians UK, Honorary Doctor of Uppsala University, Sweden and Honorary Doctor of the University of Bath, United Kingdom. He graduated from the Pharmaceutical Faculty in Uppsala 1976.

Research Interest

Regulatory and Market access